Literature DB >> 19351364

Copy number estimation algorithms and fluorescence in situ hybridization to describe copy number alterations in human tumors.

Masaya Suzuki1, Kiyoko Nagura, Hisaki Igarashi, Hong Tao, Yutaka Midorikawa, Yasuhiko Kitayama, Haruhiko Sugimura.   

Abstract

The platforms of high-resolution genetic analysis of human tumors have become popular, and several copy number estimation algorithms have been applied to the data generated by single-nucleotide polymorphism microarrays. Although comparisons have been made between several different platforms or methodologies, there has never been a robust comparison of different copy number estimation algorithms, and the validity of the estimations in comparison with multiple fluorescence in situ hybridization (FISH) data in tumors has rarely been addressed. In the present study the dataset that the Affymetrix 250K Nsp array generated in two cancer cases was used to compare the two widely used algorithms for estimating copy number alterations (CNA): the genotyping microarray-based copy number variation (CNV) analysis (GEMCA) algorithm and the copy number analyzer for Affymetrix Genechip mapping (CNAG) algorithm. Considerable differences were noticed between the estimations by these two algorithms, because of the difference in the formula used to calculate the threshold values. Both algorithms yielded highly consistent data with the FISH results, but CNAG was more stringent for detecting loss. There were areas in which both algorithms provided gains, but FISH showed no change. It will be interesting to pursue the reasons for these remaining discrepancies.

Entities:  

Mesh:

Year:  2009        PMID: 19351364     DOI: 10.1111/j.1440-1827.2009.02354.x

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  2 in total

1.  Editorial: an obsession with subtyping gastric cancer.

Authors:  Haruhiko Sugimura
Journal:  Gastric Cancer       Date:  2013-10       Impact factor: 7.370

2.  The CRKL gene encoding an adaptor protein is amplified, overexpressed, and a possible therapeutic target in gastric cancer.

Authors:  Hiroko Natsume; Kazuya Shinmura; Hong Tao; Hisaki Igarashi; Masaya Suzuki; Kiyoko Nagura; Masanori Goto; Hidetaka Yamada; Matsuyoshi Maeda; Hiroyuki Konno; Satoki Nakamura; Haruhiko Sugimura
Journal:  J Transl Med       Date:  2012-07-03       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.